Johnson & Johnson (FRA:JNJ)
€ 138.92 -0.18 (-0.13%) Market Cap: 334.68 Bil Enterprise Value: 341.56 Bil PE Ratio: 9.88 PB Ratio: 5.15 GF Score: 83/100

Johnson & Johnson Annual Shareholders Meeting Transcript

Apr 22, 2021 / 02:00PM GMT
Release Date Price: €137.5 (-0.79%)
Alex Gorsky
Johnson & Johnson - Chairman & CEO

Good morning, everyone. I'm Alex Gorsky, the Chairman and CEO of Johnson & Johnson. It is my pleasure to welcome all of you to the 2021 Annual Meeting of Shareholders. As part of our ongoing commitment to promote global health and protect the health of our shareholders, our employees and all our other stakeholders, this is the second year we are hosting our Annual Meeting of Shareholders in a virtual setting.

To begin today's webcast, I'd like to welcome our Executive Committee members. I'd also like to introduce our Board of Directors. This is an outstanding and diverse group of global business and health care leaders with deep expertise in science, policy and more. We have with us Dr. Mary Beckerle, Scott Davis, Ian Davis, Dr. Jennifer Doudna, Marillyn Hewson, Hubert Joly, Dr. Mark McClellan, Anne Mulcahy, Chuck Prince, Dr. Eugene Washington, Mark Weinberger, Dr. Nadja West and Ronald Williams. We also have on the line today, Steve Johnson and Chris King, representing PricewaterhouseCoopers, our independent auditors.

A copy

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot